|
|
Before matching |
After matching |
Codes (ICD-10, medication, or CPT) |
Diagnosis |
Cohort 1, n (%) |
Cohort 2, n (%) |
Std. diff. |
Cohort 1, n (%) |
Cohort 2, n (%) |
Std. diff. |
AI |
Age at index |
55.41 (100.000) |
56.26 (100.000) |
- |
53.79 (100.000) |
53.69 (100.000) |
- |
M |
Male |
920 (48.884) |
3230 (59.605) |
0.2165 |
337 (52.167) |
327 (50.619) |
0.030975 |
F |
Female |
962 (51.116) |
2189 (40.395) |
0.2165 |
309 (47.833) |
319 (49.381) |
0.030975 |
2106-3 |
White |
1303 (69.235) |
3824 (70.567) |
0.0290 |
451 (69.814) |
463 (71.672) |
0.04084 |
2054-5 |
Black or African American |
409 (21.732) |
910 (16.793) |
0.1255 |
139 (21.517) |
130 (20.124) |
0.034318 |
2131-1 |
Unspecified race |
142 (7.545) |
564 (10.408) |
0.1003 |
46 (7.121) |
39 (6.037) |
0.043719 |
2028-9 |
Asian |
20 (1.063) |
101 (1.864) |
0.0668 |
10 (1.548) |
13 (2.012) |
0.035126 |
I10-I16 |
Hypertensive diseases |
1476 (78.427) |
3268 (60.306) |
0.4009 |
418 (64.706) |
402 (62.229) |
0.051454 |
E78 |
Disorders of lipoprotein metabolism and other lipidemias |
982 (52.179) |
1828 (33.733) |
0.3793 |
244 (37.771) |
237 (36.687) |
0.022417 |
E08-E13 |
Diabetes mellitus, type 1 and type 2 |
786 (41.764) |
1097 (20.244) |
0.4784 |
181 (28.019) |
165 (25.542) |
0.055955 |
R53 |
Malaise and fatigue |
559 (29.702) |
1121 (20.686) |
0.2088 |
149 (23.065) |
119 (18.421) |
0.114722 |
F17 |
Nicotine dependence |
468 (24.867) |
1127 (20.797) |
0.0971 |
123 (19.040) |
104 (16.099) |
0.077343 |
I20-I25 |
Ischemic heart diseases |
525 (27.896) |
1090 (20.114) |
0.1829 |
120 (18.576) |
108 (16.718) |
0.048742 |
R13 |
Aphagia and dysphagia |
550 (29.224) |
1295 (23.897) |
0.1208 |
115 (17.802) |
108 (16.718) |
0.028677 |
J40-J47 |
Chronic lower respiratory diseases |
481 (25.558) |
825 (15.224) |
0.2586 |
107 (16.563) |
105 (16.254) |
0.00836 |
N17-N19 |
Acute kidney failure and chronic kidney disease |
501 (26.621) |
926 (17.088) |
0.2322 |
95 (14.706) |
86 (13.313) |
0.040148 |
R40 |
Somnolence, stupor, and coma |
459 (24.389) |
1214 (22.403) |
0.0469 |
82 (12.693) |
70 (10.836) |
0.057679 |
I48 |
Atrial fibrillation and flutter |
366 (19.447) |
785 (14.486) |
0.1325 |
76 (11.765) |
63 (9.752) |
0.06498 |
I50 |
Heart failure |
383 (20.351) |
610 (11.257) |
0.2513 |
71 (10.991) |
67 (10.372) |
0.020048 |
Z87.891 |
Personal history of nicotine dependence |
348 (18.491) |
587 (10.832) |
0.2178 |
65 (10.062) |
59 (9.133) |
0.031536 |
R63 |
Symptoms and signs concerning food and fluid intake |
177 (9.405) |
343 (6.330) |
0.1144 |
43 (6.656) |
42 (6.502) |
0.006244 |
I73 |
Other peripheral vascular diseases |
136 (7.226) |
232 (4.281) |
0.1267 |
35 (5.418) |
27 (4.180) |
0.057963 |
F10.1 |
Alcohol abuse |
88 (4.676) |
310 (5.721) |
0.0471 |
20 (3.096) |
16 (2.477) |
0.037629 |
F10.2 |
Alcohol dependence |
65 (3.454) |
220 (4.060) |
0.0319 |
14 (2.167) |
15 (2.322) |
0.01045 |
K74 |
Fibrosis and cirrhosis of the liver |
33 (1.753) |
60 (1.107) |
0.0544 |
<10 (<1.548) |
<10 (<1.548) |
0 |
E65-E68 |
Overweight, obesity, and other hyperalimentation |
1245 (66.153) |
10 (0.185) |
1.963531 |
<10 (<1.548) |
<10 (<1.548) |
0 |
1191 |
Aspirin |
778 (41.339) |
1632 (30.116) |
0.2358213 |
215 (33.282) |
209 (32.353) |
0.019782 |
11289 |
Warfarin |
172 (9.139) |
281 (5.185) |
0.1537802 |
36 (5.573) |
33 (5.108) |
0.020656 |
8410 |
Alteplase |
140 (7.439) |
296 (5.462) |
0.08053 |
33 (5.108) |
27 (4.180) |
0.044147 |
1364430 |
Apixaban |
65 (3.454) |
95 (1.753) |
0.1069543 |
<10 (<1.548) |
<10 (<1.548) |
0 |
1114195 |
Rivaroxaban |
34 (1.807) |
67 (1.236) |
0.0465949 |
<10 (<1.548) |
<10 (<1.548) |
0 |
259280 |
Tenecteplase |
<10 (<0.531) |
16 (0.295) |
0.0368061 |
<10 (<1.548) |
<10 (<1.548) |
0 |
31500 |
Intubation, endotracheal, emergency procedure |
173 (9.192) |
529 (9.762) |
0.0194479 |
33 (5.108) |
29 (4.489) |
0.028973 |